PMCPA Deputy Director
Etta Logan, Deputy Director, PMCPA, has resigned from her position to explore new opportunities. Etta will continue working at the PMCPA until the end of September. She has enjoyed her time at the PMCPA immensely: both the challenge and support of her colleagues and administering the Code for the ultimate benefit of the public.
I would like to acknowledge Etta’s many achievements and hard work in this demanding role over a long period of time as well as thanking her for her contributions.
I know we will all miss working with Etta and wish her every success with for the future.
Heather Simmonds
New PMCPA Director appointed
For more information click here
PMCPA Deputy Director
Etta Logan, Deputy Director, PMCPA, has resigned from her position to explore new opportunities. Etta will continue working at the PMCPA until the end of September. She has enjoyed her time at the PMCPA immensely: both the challenge and support of her colleagues and administering the Code for the ultimate benefit of the public.
I would like to acknowledge Etta’s many achievements and hard work in this demanding role over a long period of time as well as thanking her for her contributions.
I know we will all miss working with Etta and wish her every success with for the future.
Heather Simmonds
New PMCPA Director appointed
For more information click here
The Prescription Medicines Code of Practice Authority
The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, independently of the ABPI. It was established by the ABPI on 1 January 1993.
The Authority is responsible for the provision of advice, guidance and training on the Code as well as for the complaints procedure. It is also responsible for arranging for conciliation between companies when requested to do so and for arranging for the scrutiny of advertising and meetings on a regular basis.
The PMCPA was established by The Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry, independently of the ABPI.
The aim of the Code is to ensure that the promotion of medicines by the pharmaceutical industry is carried out within a robust framework, to support high quality patient care.
TRAINING
Code of Practice Seminars
- dates under review due to COVID-19
ABPI Examination for Medical Representatives
More information is available on the ABPI website, link below
To extend the time available to take the examination an application for an extension should be made on the form on this website, link below
The extension request should preferably be made by the company rather than the representative.
In house training
- under review due to COVID-19
For more information see Training Opportunities.
